APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Drug Delivery System

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Selected research

Industry Growth & Trends

Global Transdermal Drug Delivery System Industry Growth and Trends Forecast to 2032

8 January 2026111 pages

Choose your research edition.

Industry ResearchTransdermal Drug Delivery System Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Drug Delivery System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Transdermal Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Drug Delivery System Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Drug Delivery System Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

According to APO Research, the global Transdermal Drug Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Transdermal Drug Delivery System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transdermal Drug Delivery System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Drug Delivery System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Drug Delivery System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Transdermal Drug Delivery System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transdermal Drug Delivery System Market by Company

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Transdermal Drug Delivery System Segment by Type

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other

Transdermal Drug Delivery System Segment by Application

OTC

Rx

Transdermal Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Transdermal Drug Delivery System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Transdermal Drug Delivery System Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Transdermal Drug Delivery System Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Transdermal Drug Delivery System Market Share by Region (2021-2026) Table 4. Global Transdermal Drug Delivery System Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Transdermal Drug Delivery System Market Share by Region (2027-2032) Table 6. Global Transdermal Drug Delivery System Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Transdermal Drug Delivery System Market Size Share by Type (2021-2026) Table 9. Global Transdermal Drug Delivery System Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Transdermal Drug Delivery System Market Size Share Forecasted by Type (2027-2032) Table 11. North America Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Transdermal Drug Delivery System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Transdermal Drug Delivery System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Transdermal Drug Delivery System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Transdermal Drug Delivery System Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Transdermal Drug Delivery System Market Size Share by Application (2021-2026) Table 24. Global Transdermal Drug Delivery System Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Transdermal Drug Delivery System Market Size Share Forecasted by Application (2027-2032) Table 26. North America Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Transdermal Drug Delivery System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Transdermal Drug Delivery System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Transdermal Drug Delivery System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Transdermal Drug Delivery System Industry Trends Table 37. Transdermal Drug Delivery System Industry Drivers Table 38. Transdermal Drug Delivery System Industry Opportunities and Challenges Table 39. Transdermal Drug Delivery System Industry Restraints Table 40. Global Transdermal Drug Delivery System Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Transdermal Drug Delivery System Revenue Market Share by Company (2021-2026) Table 42. Global Transdermal Drug Delivery System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Transdermal Drug Delivery System Key Company Headquarters & Area Served Table 44. Global Transdermal Drug Delivery System Company, Product Type & Application Table 45. Global Transdermal Drug Delivery System Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Hisamitsu Company Information Table 49. Hisamitsu Business Overview Table 50. Hisamitsu Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Hisamitsu Transdermal Drug Delivery System Product Portfolio Table 52. Hisamitsu Recent Development Table 53. Mylan Company Information Table 54. Mylan Business Overview Table 55. Mylan Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Mylan Transdermal Drug Delivery System Product Portfolio Table 57. Mylan Recent Development Table 58. GSK Company Information Table 59. GSK Business Overview Table 60. GSK Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GSK Transdermal Drug Delivery System Product Portfolio Table 62. GSK Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Transdermal Drug Delivery System Product Portfolio Table 67. Novartis Recent Development Table 68. Teve (Actavis) Company Information Table 69. Teve (Actavis) Business Overview Table 70. Teve (Actavis) Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Teve (Actavis) Transdermal Drug Delivery System Product Portfolio Table 72. Teve (Actavis) Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Transdermal Drug Delivery System Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Lohmann Company Information Table 79. Lohmann Business Overview Table 80. Lohmann Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Lohmann Transdermal Drug Delivery System Product Portfolio Table 82. Lohmann Recent Development Table 83. Teikoku Seiyaku Company Information Table 84. Teikoku Seiyaku Business Overview Table 85. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio Table 87. Teikoku Seiyaku Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bayer Transdermal Drug Delivery System Product Portfolio Table 92. Bayer Recent Development Table 93. Lingrui Company Information Table 94. Lingrui Business Overview Table 95. Lingrui Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Lingrui Transdermal Drug Delivery System Product Portfolio Table 97. Lingrui Recent Development Table 98. Sanofi Company Information Table 99. Sanofi Business Overview Table 100. Sanofi Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sanofi Transdermal Drug Delivery System Product Portfolio Table 102. Sanofi Recent Development Table 103. Qizheng Company Information Table 104. Qizheng Business Overview Table 105. Qizheng Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Qizheng Transdermal Drug Delivery System Product Portfolio Table 107. Qizheng Recent Development Table 108. Endo Company Information Table 109. Endo Business Overview Table 110. Endo Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Endo Transdermal Drug Delivery System Product Portfolio Table 112. Endo Recent Development Table 113. Huarun 999 Company Information Table 114. Huarun 999 Business Overview Table 115. Huarun 999 Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Huarun 999 Transdermal Drug Delivery System Product Portfolio Table 117. Huarun 999 Recent Development Table 118. Haw Par Company Information Table 119. Haw Par Business Overview Table 120. Haw Par Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Haw Par Transdermal Drug Delivery System Product Portfolio Table 122. Haw Par Recent Development Table 123. Nichiban Company Information Table 124. Nichiban Business Overview Table 125. Nichiban Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Nichiban Transdermal Drug Delivery System Product Portfolio Table 127. Nichiban Recent Development Table 128. Mentholatum Company Information Table 129. Mentholatum Business Overview Table 130. Mentholatum Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Mentholatum Transdermal Drug Delivery System Product Portfolio Table 132. Mentholatum Recent Development Table 133. Laboratoires Genevrier Company Information Table 134. Laboratoires Genevrier Business Overview Table 135. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio Table 137. Laboratoires Genevrier Recent Development Table 138. North America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Transdermal Drug Delivery System Market Share by Country (2021-2026) Table 141. North America Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Transdermal Drug Delivery System Market Share Forecast by Country (2027-2032) Table 143. Europe Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Transdermal Drug Delivery System Market Share by Country (2021-2026) Table 146. Europe Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Transdermal Drug Delivery System Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2021-2026) Table 151. Asia-Pacific Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Transdermal Drug Delivery System Market Share Forecast by Country (2027-2032) Table 153. Latin America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Transdermal Drug Delivery System Market Share by Country (2021-2026) Table 156. Latin America Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Transdermal Drug Delivery System Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2021-2026) Table 161. Middle East & Africa Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Transdermal Drug Delivery System Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Transdermal Drug Delivery System Product Image Figure 3. Global Transdermal Drug Delivery System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 5. Global Transdermal Drug Delivery System Market Share by Region: 2025 VS 2032 Figure 6. Global Transdermal Drug Delivery System Market Share by Region (2021-2032) Figure 7. North America Transdermal Drug Delivery System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Transdermal Drug Delivery System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Transdermal Drug Delivery System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Fentanyl Image Figure 13. Global Fentanyl Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Nitroglycerin Image Figure 15. Global Nitroglycerin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Estradiol Image Figure 17. Global Estradiol Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Nicotine Image Figure 19. Global Nicotine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Transdermal Drug Delivery System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Transdermal Drug Delivery System Market Share by Type 2025 VS 2032 Figure 24. North America Transdermal Drug Delivery System Market Size Share by Type (2021-2032) Figure 25. Europe Transdermal Drug Delivery System Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Transdermal Drug Delivery System Market Size Share by Type (2021-2032) Figure 27. Latin America Transdermal Drug Delivery System Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Transdermal Drug Delivery System Market Size Share by Type (2021-2032) Figure 29. OTC Image Figure 30. Global OTC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Rx Image Figure 32. Global Rx Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Transdermal Drug Delivery System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Transdermal Drug Delivery System Market Share by Application 2025 VS 2032 Figure 35. North America Transdermal Drug Delivery System Market Size Share by Application (2021-2032) Figure 36. Europe Transdermal Drug Delivery System Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Transdermal Drug Delivery System Market Size Share by Application (2021-2032) Figure 38. Latin America Transdermal Drug Delivery System Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Transdermal Drug Delivery System Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Transdermal Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Transdermal Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 45. Europe Transdermal Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Transdermal Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 48. Asia-Pacific Transdermal Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Transdermal Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 51. Latin America Transdermal Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Transdermal Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 54. Middle East & Africa Transdermal Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Transdermal Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Nitroglycerin
  • Estradiol
  • Nicotine
  • Other
Applications
  • OTC
  • Rx
Companies covered
  • Hisamitsu
  • Mylan
  • GSK
  • Novartis
  • Teve (Actavis)
  • Johnson & Johnson
  • Lohmann
  • Teikoku Seiyaku
  • Bayer
  • Lingrui
  • Sanofi
  • Qizheng
  • Endo
  • Huarun 999
  • Haw Par
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Transdermal Drug Delivery System Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Transdermal Drug Delivery System Market Size by Region (2021-2032)
  5. 1.4.1 Global Transdermal Drug Delivery System Market Size by Region (2021-2026)
  6. 1.4.2 Global Transdermal Drug Delivery System Market Size by Region (2027-2032)
  7. 1.5 Key Regions Transdermal Drug Delivery System Market Size (2021-2032)
  8. 1.5.1 North America Transdermal Drug Delivery System Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Transdermal Drug Delivery System Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Transdermal Drug Delivery System Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (2021-2032)
2 Transdermal Drug Delivery System Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Fentanyl
  3. 2.1.2 Nitroglycerin
  4. 2.1.3 Estradiol
  5. 2.1.4 Nicotine
  6. 2.1.5 Other
  7. 2.2 Global Transdermal Drug Delivery System Market Size by Type
  8. 2.2.1 Global Transdermal Drug Delivery System Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Transdermal Drug Delivery System Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Transdermal Drug Delivery System Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Transdermal Drug Delivery System Market Size by Regions
  12. 2.3.1 North America Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Type (2021-2026)
3 Transdermal Drug Delivery System Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 OTC
  3. 3.1.2 Rx
  4. 3.2 Global Transdermal Drug Delivery System Market Size by Application
  5. 3.2.1 Global Transdermal Drug Delivery System Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Transdermal Drug Delivery System Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Transdermal Drug Delivery System Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Transdermal Drug Delivery System Market Size by Regions
  9. 3.3.1 North America Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Transdermal Drug Delivery System Industry Trends
  2. 4.2 Transdermal Drug Delivery System Industry Drivers
  3. 4.3 Transdermal Drug Delivery System Industry Opportunities and Challenges
  4. 4.4 Transdermal Drug Delivery System Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Transdermal Drug Delivery System Revenue (2021-2026)
  2. 5.2 Global Transdermal Drug Delivery System Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Transdermal Drug Delivery System Key Company Headquarters & Area Served
  4. 5.4 Global Transdermal Drug Delivery System Company, Product Type & Application
  5. 5.5 Global Transdermal Drug Delivery System Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Transdermal Drug Delivery System Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Transdermal Drug Delivery System Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Hisamitsu
  2. 6.1.1 Hisamitsu Company Information
  3. 6.1.2 Hisamitsu Business Overview
  4. 6.1.3 Hisamitsu Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
  6. 6.1.5 Hisamitsu Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GSK Transdermal Drug Delivery System Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Teve (Actavis)
  26. 6.5.1 Teve (Actavis) Company Information
  27. 6.5.2 Teve (Actavis) Business Overview
  28. 6.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
  30. 6.5.5 Teve (Actavis) Recent Developments
  31. 6.6 Johnson & Johnson
  32. 6.6.1 Johnson & Johnson Company Information
  33. 6.6.2 Johnson & Johnson Business Overview
  34. 6.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
  36. 6.6.5 Johnson & Johnson Recent Developments
  37. 6.7 Lohmann
  38. 6.7.1 Lohmann Company Information
  39. 6.7.2 Lohmann Business Overview
  40. 6.7.3 Lohmann Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
  42. 6.7.5 Lohmann Recent Developments
  43. 6.8 Teikoku Seiyaku
  44. 6.8.1 Teikoku Seiyaku Company Information
  45. 6.8.2 Teikoku Seiyaku Business Overview
  46. 6.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
  48. 6.8.5 Teikoku Seiyaku Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 Lingrui
  56. 6.10.1 Lingrui Company Information
  57. 6.10.2 Lingrui Business Overview
  58. 6.10.3 Lingrui Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
  60. 6.10.5 Lingrui Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Qizheng
  68. 6.12.1 Qizheng Company Information
  69. 6.12.2 Qizheng Business Overview
  70. 6.12.3 Qizheng Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
  72. 6.12.5 Qizheng Recent Developments
  73. 6.13 Endo
  74. 6.13.1 Endo Company Information
  75. 6.13.2 Endo Business Overview
  76. 6.13.3 Endo Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Endo Transdermal Drug Delivery System Product Portfolio
  78. 6.13.5 Endo Recent Developments
  79. 6.14 Huarun 999
  80. 6.14.1 Huarun 999 Company Information
  81. 6.14.2 Huarun 999 Business Overview
  82. 6.14.3 Huarun 999 Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
  84. 6.14.5 Huarun 999 Recent Developments
  85. 6.15 Haw Par
  86. 6.15.1 Haw Par Company Information
  87. 6.15.2 Haw Par Business Overview
  88. 6.15.3 Haw Par Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
  90. 6.15.5 Haw Par Recent Developments
  91. 6.16 Nichiban
  92. 6.16.1 Nichiban Company Information
  93. 6.16.2 Nichiban Business Overview
  94. 6.16.3 Nichiban Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
  96. 6.16.5 Nichiban Recent Developments
  97. 6.17 Mentholatum
  98. 6.17.1 Mentholatum Company Information
  99. 6.17.2 Mentholatum Business Overview
  100. 6.17.3 Mentholatum Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
  102. 6.17.5 Mentholatum Recent Developments
  103. 6.18 Laboratoires Genevrier
  104. 6.18.1 Laboratoires Genevrier Company Information
  105. 6.18.2 Laboratoires Genevrier Business Overview
  106. 6.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
  108. 6.18.5 Laboratoires Genevrier Recent Developments
7 North America
  1. 7.1 North America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Transdermal Drug Delivery System Market Size by Country (2021-2026)
  3. 7.3 North America Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Transdermal Drug Delivery System Market Size by Country (2021-2026)
  3. 8.3 Europe Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Transdermal Drug Delivery System Market Size by Country (2021-2026)
  3. 10.3 South America Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Transdermal Drug Delivery System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst